HNIL logo

Himalaya Nutravedics India Ltd

HNIL · BSE 544943 · Healthcare

₹184.90+₹6.203.47%Prev. close ₹178.70
At close: 17 Nov 2026, 3:30 PM India time · NSE
Market cap
₹162 Cr
P/E (last FY)
—
Forward P/E
—
Open
₹172.05
Day range
₹172.05 – ₹184.90
52W range
₹109.95 – ₹188.95
EPS (last FY)
—
Dividend yield
—
Volume
7,200
P/B
3.44
ROE
—
Debt / equity
—

P/B is the price over the book value per share at Sept 2026.

News

Financials

Earnings

Valuation

Ownership

Business

Technicals

Your research

Himalaya Nutravedics India Ltd (HNIL): company summary

Himalaya Nutravedics India Ltd (HNIL) is a micro-cap Healthcare company valued at ₹162 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.

Himalaya Nutravedics India Ltd (HNIL) is a micro-cap Healthcare company valued at ₹162 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.

Recent price move
Himalaya Nutravedics India Ltd last traded at ₹184.9, up 3.47% on the day.
Valuation multiples
A price-to-earnings ratio is not meaningful here; the stock trades at 3.44 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

HNILFree with a DocStoX account

Himalaya Nutravedics India Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.